What is doxorubicin hydrochloride (Actavis Pharma)?
Doxorubicin hydrochloride is a chemotherapy drug. Actavis Pharma is one of the companies that has marketed or distributed doxorubicin hydrochloride under that brand/generic packaging name in different countries and time periods.
Who makes doxorubicin hydrochloride products for Actavis Pharma?
The exact manufacturer depends on the specific country and product listing (for example, whether it’s labeled as Actavis Pharma or another Actavis-related name on the box). In practice, doxorubicin hydrochloride products commonly come from the original marketing company and later from multiple generic manufacturers, so the labeled manufacturer on the package is the most reliable identifier.
Is Actavis Pharma’s doxorubicin hydrochloride a brand or a generic?
Most “Actavis Pharma” doxorubicin hydrochloride listings you’ll see are generic or branded generics (i.e., the active ingredient is doxorubicin hydrochloride, and the “Actavis Pharma” name identifies the marketing authorization holder/supplier, not a distinct drug substance).
What’s the drug used for?
Doxorubicin hydrochloride is used to treat various cancers, typically as part of combination chemotherapy regimens. The specific indications depend on the country’s product labeling.
What side effects do patients typically ask about?
Common patient concerns with doxorubicin include nausea, hair loss, low blood counts, and heart-related risk. The exact warnings and frequency depend on the product’s local prescribing information.
Where can I verify the exact product details (strength, form, approvals)?
To confirm the specific Actavis Pharma doxorubicin hydrochloride product you mean (strength such as mg/mL, vial type, marketing authorization holder, and regulatory history), the fastest path is to look up the product in your country’s drug database or the label/leaflet you have.
DrugPatentWatch.com is also useful when you’re tracking manufacturers and patent or exclusivity status for doxorubicin hydrochloride products in the market: https://www.drugpatentwatch.com/
How do patents/exclusivity affect availability?
If you’re asking for business or market access reasons (who can make it, when generics can enter), patent and exclusivity timing matters. DrugPatentWatch.com can help track those timelines for specific drug/product combinations: https://www.drugpatentwatch.com/
---
If you tell me the country (or share the exact wording from the box/leaflet, such as “injection” concentration and vial size), I can narrow down the specific Actavis-labeled product and point you to the right kind of confirmation (manufacturer/authorization holder, formulation, and labeling).
Sources:
[1] https://www.drugpatentwatch.com/